LEADER 01852nam  2200409   450 
001 9910688358303321
005 20230704164953.0
035   $a(CKB)5850000000050289
035   $a(NjHacI)995850000000050289
035   $a(EXLCZ)995850000000050289
100   $a20230704d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAnticoagulation $eCurrent Perspectives /$fedited by Xingshun Qi and Xiaozhong Guo
210  1$aLondon :$cIntechOpen,$d2022.
210  4$dİ2022
215   $a1 online resource (ix, 138 pages) $cillustrations
311   $a1-80355-893-8 
320   $aIncludes bibliographical references.
330   $aThrombotic diseases are some of the leading causes of death in the world. Anticoagulation is a mainstay approach for the prophylaxis and treatment of thrombotic diseases. This book includes six chapters regarding the mechanisms of anticoagulation and its clinical value in different disease conditions. The first two chapters summarize the general information regarding anticoagulation and hypercoagulability/thrombophilia, and the remaining four chapters discuss the use of anticoagulation in different populations, including adult hospitalized surgical and medical patients, COVID-19 patients, patients with hepatic thrombotic disorders, and frail elderly patients with atrial fibrillation.
517   $aAnticoagulation 
606   $aHematology
606   $aAnticoagulants (Medicine)
615  0$aHematology.
615  0$aAnticoagulants (Medicine)
676   $a616.15
702   $aQi$b Xingshun$f1984-
702   $aGuo$b Xiaozhong
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688358303321
996   $aAnticoagulation$92959454
997   $aUNINA